Axon Enterprise Files 8-K on Equity Sales & Other Events
Ticker: AXON · Form: 8-K · Filed: Dec 10, 2025 · CIK: 1069183
Sentiment: neutral
Topics: equity-sale, corporate-event, filing
Related Tickers: AXON
TL;DR
Axon filed an 8-K detailing unregistered equity sales and other events as of Dec 9, 2025.
AI Summary
Axon Enterprise, Inc. filed an 8-K on December 10, 2025, reporting on unregistered sales of equity securities and other events. The filing details information related to the company's operations and financial reporting, with the earliest event reported as of December 9, 2025. Axon Enterprise, Inc., formerly TASER INTERNATIONAL INC, is incorporated in Delaware and headquartered in Scottsdale, Arizona.
Why It Matters
This 8-K filing provides crucial updates on Axon Enterprise's financial activities, specifically concerning unregistered equity sales, which can impact share structure and investor perception.
Risk Assessment
Risk Level: low — The filing is a standard 8-K reporting an event, not indicating immediate financial distress or significant new risks.
Key Players & Entities
- AXON ENTERPRISE, INC. (company) — Registrant
- TASER INTERNATIONAL INC (company) — Former company name
- Delaware (jurisdiction) — State of incorporation
- Scottsdale, Arizona (location) — Principal executive offices
- December 9, 2025 (date) — Date of earliest event reported
- December 10, 2025 (date) — Date of report
FAQ
What specific type of unregistered equity securities were sold by Axon Enterprise, Inc.?
The filing indicates 'Unregistered Sales of Equity Securities' as an item of information, but does not specify the type of securities in the provided text.
What were the 'Other Events' reported by Axon Enterprise, Inc. in this 8-K?
The filing lists 'Other Events' as an item of information but does not provide details on what those events are within the provided text.
When was Axon Enterprise, Inc. formerly known as TASER INTERNATIONAL INC?
The date of name change from TASER INTERNATIONAL INC to Axon Enterprise, Inc. was February 12, 2001.
What is the principal business address of Axon Enterprise, Inc.?
The principal executive offices are located at 17800 N. 85th St., Scottsdale, Arizona 85255.
What is the SEC file number for Axon Enterprise, Inc.?
The SEC file number for Axon Enterprise, Inc. is 001-16391.
Filing Stats: 1,453 words · 6 min read · ~5 pages · Grade level 14.1 · Accepted 2025-12-10 08:45:17
Key Financial Figures
- $0.00001 — ange on which registered Common Stock, $0.00001 Par Value AXON The NASDAQ Stock Market
- $177.9 million — g conditions, to exchange approximately $177.9 million aggregate principal amount of the Notes
- $550.95 — on stock during the averaging period is $550.95 (the closing price of the common stock
- $100.1 million — 5, the Company would have approximately $100.1 million aggregate principal amount of Notes out
Filing Documents
- axon-20251209.htm (8-K) — 33KB
- 0001628280-25-056229.txt ( ) — 147KB
- axon-20251209.xsd (EX-101.SCH) — 2KB
- axon-20251209_lab.xml (EX-101.LAB) — 21KB
- axon-20251209_pre.xml (EX-101.PRE) — 12KB
- axon-20251209_htm.xml (XML) — 3KB
02 Unregistered Sales of Equity Securities
Item 3.02 Unregistered Sales of Equity Securities The information set forth under Item 8.01 below with respect to the shares of common stock to be issued pursuant to the Exchange Agreements (as defined herein) is incorporated into this Item 3.02 by reference, insofar as it relates to the unregistered sales of equity securities.
01 Other Events
Item 8.01 Other Events On December 9, 2025, Axon Enterprise, Inc. (the "Company") entered into separate, privately negotiated agreements (the "Exchange Agreements") with certain holders (the "Holders") of the Company's 0.50% convertible senior notes due 2027 (the "Notes"). Pursuant to these Exchange Agreements, the Company and the Holders have agreed, subject to customary closing conditions, to exchange approximately $177.9 million aggregate principal amount of the Notes for exchange consideration consisting of cash and shares of its common stock that will be determined over a one trading day averaging period on December 10, 2025. Assuming the per share volume-weighted average price of the common stock during the averaging period is $550.95 (the closing price of the common stock on December 5, 2025), the Company expects to issue an aggregate of approximately 468,000 shares of common stock upon consummation of the exchanges. The cash portion of the exchange consideration will include cash for the aggregate principal amount of the Notes being exchanged and cash in lieu of any fractional shares of common stock, as well as a cash payment for accrued and unpaid interest on the Notes being exchanged. Following the closing of the exchanges, which is expected to occur on or about December 16, 2025, the Company would have approximately $100.1 million aggregate principal amount of Notes outstanding. In connection with these exchanges, the Company expects the various exchange agreement counterparties who have hedged their equity price risk with respect to the Notes being exchanged (the "hedged holders") will unwind all or part of their hedge positions by purchasing the Company's common stock and/or entering into or unwinding various derivative transactions with respect to the Company's common stock. The amount of the Company's common stock to be purchased by the hedged holders or the notional number of shares of the Company's common stock underlying such derivative transac
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits (d) Exhibits Exhibit Number Exhibit Description 104 The cover page from this Current Report on Form 8-K, formatted as Inline XBRL SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: December 10, 2025 Axon Enterprise, Inc. By: /s/ BRITTANY BAGLEY Brittany Bagley Chief Operating Officer and Chief Financial Officer